Rouleau J - Search Results

1

Integrating High-Sensitivity Troponin T and Sacubitril/Valsartan Treatment in HFpEF: The PARAGON-HF Trial.

Gori M, Senni M, Claggett B, Liu J, Maggioni AP, Zile M, Prescott MF, Van Veldhuisen DJ, Zannad F, Pieske B, Lam CSP, Rouleau J, Jhund P, Packer M, Pfeffer MA, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Gori M, et al. Among authors: rouleau j. JACC Heart Fail. 2021 Sep;9(9):627-635. doi: 10.1016/j.jchf.2021.04.009. Epub 2021 Jul 7. JACC Heart Fail. 2021. PMID: 34246603 Free article.

2

Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure.

Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW. Johnson W, et al. J Am Coll Cardiol. 2002 May 15;39(10):1623-9. doi: 10.1016/s0735-1097(02)01814-4. J Am Coll Cardiol. 2002. PMID: 12020489 Free article.

3

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

Packer M, Califf RM, Konstam MA, Krum H, McMurray JJ, Rouleau JL, Swedberg K. Packer M, et al. Among authors: rouleau jl. Circulation. 2002 Aug 20;106(8):920-6. doi: 10.1161/01.cir.0000029801.86489.50. Circulation. 2002. PMID: 12186794 Clinical Trial.

4

Expression and regulation of ST2, an interleukin-1 receptor family member, in cardiomyocytes and myocardial infarction.

Weinberg EO, Shimpo M, De Keulenaer GW, MacGillivray C, Tominaga S, Solomon SD, Rouleau JL, Lee RT. Weinberg EO, et al. Circulation. 2002 Dec 3;106(23):2961-6. doi: 10.1161/01.cir.0000038705.69871.d9. Circulation. 2002. PMID: 12460879 Free PMC article.

5

Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarction.

Manes C, Pfeffer MA, Rutherford JD, Greaves S, Rouleau JL, Arnold JM, Menapace F, Solomon SD. Manes C, et al. Among authors: rouleau jl. Am J Med. 2003 Feb 1;114(2):99-105. doi: 10.1016/s0002-9343(02)01424-9. Am J Med. 2003. PMID: 12586228

6

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy.

Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Parikh CR, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ; Irbesartan Diabetic Nephropathy Trial. Collaborative Study Group. Berl T, et al. Among authors: rouleau jl. Ann Intern Med. 2003 Apr 1;138(7):542-9. doi: 10.7326/0003-4819-138-7-200304010-00010. Ann Intern Med. 2003. PMID: 12667024 Clinical Trial.

7

Comparative impact of enalapril, candesartan or metoprolol alone or in combination on ventricular remodelling in patients with congestive heart failure.

McKelvie RS, Rouleau JL, White M, Afzal R, Young JB, Maggioni AP, Held P, Yusuf S. McKelvie RS, et al. Eur Heart J. 2003 Oct;24(19):1727-34. doi: 10.1016/s0195-668x(03)00477-9. Eur Heart J. 2003. PMID: 14522567 Clinical Trial.

8

Adverse mortality effect of central sympathetic inhibition with sustained-release moxonidine in patients with heart failure (MOXCON).

Cohn JN, Pfeffer MA, Rouleau J, Sharpe N, Swedberg K, Straub M, Wiltse C, Wright TJ; MOXCON Investigators. Cohn JN, et al. Among authors: rouleau j. Eur J Heart Fail. 2003 Oct;5(5):659-67. doi: 10.1016/s1388-9842(03)00163-6. Eur J Heart Fail. 2003. PMID: 14607206 Free article. Clinical Trial.

9

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.

Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Køber L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM; Valsartan in Acute Myocardial Infarction Trial Investigators. Pfeffer MA, et al. Among authors: rouleau jl. N Engl J Med. 2003 Nov 13;349(20):1893-906. doi: 10.1056/NEJMoa032292. Epub 2003 Nov 10. N Engl J Med. 2003. PMID: 14610160 Free article. Clinical Trial.

10

Effect of antecedent systemic hypertension on subsequent left ventricular dilation after acute myocardial infarction (from the Survival and Ventricular Enlargement trial).

Kenchaiah S, Pfeffer MA, St John Sutton M, Plappert T, Rouleau JL, Lamas GA, Sasson Z, Parker JO, Geltman EM, Solomon SD. Kenchaiah S, et al. Am J Cardiol. 2004 Jul 1;94(1):1-8. doi: 10.1016/j.amjcard.2004.03.020. Am J Cardiol. 2004. PMID: 15219499

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

739 results

Search Page